General Updates

November 06, 2026 To, To, The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 30 of the SEBI Listing Regulations, this is to inform you that BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”) have each imposed a fine of Rs. 1,80,000/- (Rupees One Lakh Eighty Thousand only) (excluding GST) (“Fine”) on the Company for non-compliance with Regulation 17(1) of the SEBI Listing Regulations. The said fine comprised 0.000269% of the Company's market capitalisation. In this regard, we wish to further inform you that the Company has duly paid the aforesaid fines to BSE and NSE. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided herewith as ‘Annexure-I’. Kindly take the above intimation on record. Yours faithfully, For Bliss GVS Pharma Limited Aditi H. Bhatt Company Secretary & Compliance Officer Encl: As above Annexure - I Sr. No. Particulars Details i. Name of the authority BSE and NSE ii. Nature and details of the action(s) taken, A fine of Rs. 1,80,000/- (excluding or order(s) passed GST) by each BSE and NSE. iii. Date of receipt of direction or order, August 25, 2026 (received by us including any ad-interim or interim orders, around 06:57 PM and 10:41 PM, or any other communication from the respectively) authority iv. Details of the violation(s)/ contravention(s) Regulation 17(1) -Non-compliance committed or alleged to be committed with the requirements pertaining to the composition of the Board including failure to appoint woman director. v Impact on financial, operation or other Nil, except to the extent of the fine activities of the listed entity, quantifiable in imposed by BSE and NSE. monetary terms to the extent possible. vi Reason for delay The delay in filing the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was inadvertent and occurred on account of the time taken for internal coordination and verification of the relevant information pertaining to the fines imposed by the Stock Exchanges. Consequently, the disclosure could not be made within the prescribed timeline. The Company regrets the delay and has taken due note of the same. The Company is strengthening its internal reporting and monitoring mechanisms to ensure timely identification and disclosure of material events and information in compliance with the applicable provisions of the SEBI Listing Regulations.